Elanco (ELAN) EVP Modi receives 56.1357 deferred stock units in Form 4 filing

Rhea-AI Filing Summary

Elanco Animal Health executive Rajeev A. Modi reported a routine equity award. On February 6, 2026, he acquired 56.1357 deferred stock units at a reference price of $25.2 per unit. Following this transaction, he beneficially owned 7,594.4613 deferred stock units, held directly.

Each deferred stock unit represents the right to receive either one share of Elanco common stock or the cash equivalent. These units settle in cash or shares after termination of employment or in a specified future year under the company’s Executive Deferral and Stock Match Plan.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Modi Rajeev A.

Role SEE REMARKS

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	56.1357	$25.20	$1K

Holdings After Transaction: Deferred Stock Units — 7,594.4613 shares (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/10/2026 - 04:32 PM Learn about SEC filing dates

FAQ

What insider transaction did Elanco (ELAN) report for Rajeev A. Modi?

Elanco reported that executive Rajeev A. Modi acquired 56.1357 deferred stock units. The transaction occurred on February 6, 2026 and increased his directly held deferred stock unit balance to 7,594.4613 units under the company’s executive deferral program.

How many deferred stock units does Rajeev A. Modi hold at Elanco (ELAN) after this filing?

After the reported transaction, Rajeev A. Modi beneficially owns 7,594.4613 deferred stock units. This total reflects the addition of 56.1357 units granted on February 6, 2026, all held directly according to the Form 4 disclosure.

What are deferred stock units in Elanco (ELAN)’s executive plans?

Each Elanco deferred stock unit represents a right to one share of common stock or its cash equivalent. The units are part of the Executive Deferral and Stock Match Plan and are designed to settle in cash or shares at a later date, typically after employment ends.

When do Elanco (ELAN) deferred stock units for Rajeev A. Modi settle?

The deferred stock units settle in cash or shares following termination of employment or in a specified future year. Settlement timing is governed by Elanco’s Executive Deferral and Stock Match Plan, which outlines when and how executives receive the underlying value.

What role does Rajeev A. Modi hold at Elanco (ELAN)?

Rajeev A. Modi serves as Executive Vice President U.S. Pet Health and Global Digital Transformation. This senior leadership position is noted in the Form 4 remarks section and helps explain his eligibility for deferred stock units under Elanco’s executive compensation programs.

Was the Elanco (ELAN) insider transaction a purchase or an award?

The Form 4 lists the transaction with code “A,” indicating an acquisition of derivative securities. In this context, it reflects a grant or accrual of 56.1357 deferred stock units to the executive, rather than an open-market purchase of common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Modi Rajeev A.

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEE REMARKS

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	02/06/2026		A		56.1357		(2)	(2)	Common Stock	56.1357	$25.2	7,594.4613	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Remarks:

Executive Vice President U.S. Pet Health and Global Digital Transformation

	/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.